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We designed a cell culture-based system to test the hypothesis that recombination events during HIV-1 replication would be more frequent
near the dimerization initiation sequence (DIS). A 459-bp region spanning the DIS through the 5V-end of gag was sequenced and analyzed to
determine the frequency and distribution of crossover sites. We found a strong preference for recombination events occurring within a 112-nt-
long region encompassing the gag AUG (64% of crossovers occurred in this region, compared to 10–14% in surrounding regions with
similar lengths). Surprisingly, the region immediately surrounding the DIS was not a preferred site of recombination. Analysis of
recombination events using RNA templates transcribed in vitro revealed a preference for crossover sites at the start of the gag coding region,
similar to that observed in cell culture. This recombinogenic region was unusually G-rich and promoted extensive pausing by RT in vitro.
Template features that induce RT pausing very likely contribute to the observed template switching events in gag during minus-strand
synthesis. The region in gag that was a preferred site for recombination also had an approximately 2-fold higher mutation frequency
compared to the rest of the region sequenced, but mutations were no more common in recombinant compared to non-recombinant clones,
suggesting that recombination events were not mutagenic.
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Introduction during reverse transcription each contribute to retroviralThe ability of HIV-1 to evolve rapidly in response to
changes in selective pressure is a major barrier to the
development of effective vaccines and treatments for this
infection. Retroviral diversity is generated primarily during
reverse transcription, a multi-step process in which the
virally encoded reverse transcriptase (RT) generates dou-
ble-stranded proviral DNA from the positive sense, single-
stranded viral RNA genome (reviewed in Telesnitsky and
Goff, 1997). Recombination and mutation events that occur0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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1992; Preston et al., 1988; Quinones-Mateu et al., 2002;
Roberts et al., 1988, 1995; Temin, 1993).
Retroviral recombination is possible because each virion
contains two copies of the positive sense, single-stranded
RNA genome (Hu and Temin, 1990a). Recombination
occurs during reverse transcription when a newly synthe-
sized DNA strand is transferred from the original template
(or donor) to the second template (or acceptor), and can take
place during minus-strand or plus-strand synthesis (Hu and
Temin, 1990b; Stuhlmann and Berg, 1992; Yu et al., 1998).
Strand transfer by RT is required for the completion of
minus-strong stop and plus-strong stop DNA synthesis. At
both these steps, strand transfer to the opposite end of the
genome is required in order for DNA synthesis to proceed to
completion. Strand transfers that are not essential for com-
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the length of the genome, during DNA polymerization by
RT (Brincat et al., 2002; Delviks and Pathak, 1999; DeSte-
fano et al., 1992; Peliska and Benkovic, 1992; Pfeiffer et al.,
2000; Svarovskaia et al., 2000). When such transfer events
occur between two nonidentical or genetically distinct RNA
genomes, they result in a recombinant provirus.
Several tissue culture-based systems have been designed
to look at retroviral recombination (Anderson et al., 1998;
Bowman et al., 1998; Hu and Temin, 1990a, 1900b; Hu et
al., 1997; Stuhlmann and Berg, 1992). These model systems
produce heterozygous virions by stable transfection of a
packaging cell line with two different parental viruses, each
of which expresses a selectable marker. Recombination
during reverse transcription of the two nonidentical RNA
genomes results in a recombinant provirus that expresses
both markers and is therefore easily selected. Studies using
these model systems demonstrate that recombination occurs
primarily during minus-strand synthesis, and exhibits high
negative interference (Hu et al., 1997; Zhang et al., 2000).
In addition, recombination events were rarely observed
unless the two parental strains were co-packaged in the
same virion.
Work by Dougherty et al. has emphasized the widespread
occurrence of recombination throughout the HIV-1 genome
(Jetzt et al., 2000; Yu et al., 1998; Zhuang et al., 2002).
Using a heteroduplex tracking assay (HTA), these studies
have evaluated the location and frequency of recombination
events within the HIV-1 genome, during a single reverse
transcription cycle. An average of three crossovers was
detected per genome per replication cycle. In one study, a
slightly higher frequency of crossovers was observed at the
5V-end of the pol coding region relative to the rest of the
genome (Jetzt et al., 2000). In a more recent study, sequence
analysis of a relatively small number of recombinants was
suggestive of preferred sites of recombination in HIV
(Zhuang et al., 2002).
The mechanisms leading to the promotion or inhibition
of recombination at specific sites is poorly understood.
Nonetheless, studies in vitro using purified components
have provided insights into the strand transfer mechanism
as well as template and protein factors that influence the
process. RNA structures in the genome that cause pausing
of the RT have been proposed to promote recombination
(DeStefano et al., 1992, 1994; Diaz and DeStefano, 1996;
Harrison et al., 1998; Kim et al., 1997; Palaniappan et al.,
1996; Roda et al., 2002; Wu et al., 1995). Pausing was
shown to enhance the RNase H activity of RT thereby
facilitating template switching. We recently demonstrated in
vitro, using RNA templates harboring the HIV-1 dimeriza-
tion initiation sequence (DIS), that dimerization promotes
recombination by a local proximity effect (Balakrishnan et
al., 2001, 2003).
We wished to evaluate whether the region immediately
surrounding the DIS was a preferred site for recombination
in vivo. We designed a tissue culture model system to detectrecombination events in the region near the DIS during
reverse transcription, using env-deleted, pseudotyped HIV-1
vectors. We used two parental strains that differed by
approximately 1/25 bases over a 5.1-kb region spanning
the DIS through vpr, and analyzed recombination events
with a 459-bp region of the provirus, spanning the DIS
through the beginning of gag. The region includes hairpins
and sequence features that affect RNA folding and pausing
of the RT. The segment is large enough such that the effects
of a wide variety of RNA sequence and structural features
can be examined with respect to their relative contributions
to recombination. Because of the unique features of our
model system, we were able to map the location of recom-
bination events at a high resolution. Using this model
system, we have identified a preferred region for recombi-
nation near the beginning of gag, but found no preference
for recombination occurring in regions closer to the DIS.
Analysis of the region using a strand transfer assay system
in vitro revealed transfer switching profiles within the 5V
gag region similar to what we have observed in cell culture.Results
Experimental design
To measure the location of recombination events in the
HIV-1 genome during reverse transcription, we designed
two replication-defective, env-deleted HIV-1 vectors:
pDHIV.3.B71 and pDHIV.3.Thy.1.JRCSF.KL9 (Fig. 1). To
create a system that would allow the identification of
recombinants by sequencing, we replaced the HIVNL4-3
BssHII/SalI fragment in pDHIV.3.Thy-1, encoding the gag,
pol, vif, and vpr genes, with the corresponding fragment from
pYK-JRCSF. Alignment of these regions from the two
isolates shows an average of one substitution approximately
every 25 bases, allowing fine mapping of crossover locations.
In addition, the inclusion of a JRCSF marker upstream of the
BssHII restriction site by mutagenesis (proviral positions
667–668) allowed for the identification of recombinants
across the DIS hairpin. The human co-stimulatory gene,
B7.1, and the murine Thy1.2 gene were substituted for nef
in pDHIV.3.B7.1 and pDHIV.3.Thy1.JRCSF.KL9, respec-
tively. The levels of B7.1 and Thy.1 protein expressed on the
cell surface were measured using flow cytometry. These
design features allow one to monitor the efficiency and
reproducibility of the co-infection step and obviate the need
for the production of stably infected cell lines.
Fig. 2 details the experimental design used to create virus
stocks from dually infected cells and to identify recombi-
nants. This tissue culture model consists of three separate
steps: (1) production of infectious homozygous parental virus
stocks, (2) production of virus stocks from dually infected
cells, and (3) screening for recombinant proviruses by se-
quence analysis of a PCR-amplified region of proviral DNA.
More than a single round of infection is possible in Steps 1
Fig. 1. Maps of (A) pDHIV.3.B7.1 and (B) pDHIV.3.Thy-1.JRCSF.KL9. HIVNL4-3 sequence is shown in red and HIVJRCSF is shown in green. The SV40
origin of replication is shown in black. The blue bar represents the B7.1 open reading frame (ORF) and the Thy1.2 ORF is shown in purple. The approximate
location of the DIS hairpin near the 5V-end of the genome is shown as a stem– loop structure. The deletion in env is shown as a red triangle. The locations of
restriction enzyme sites used to construct each vector are each marked with a vertical line and labeled with the nucleotide position. See Materials and methods
for details on the construction of each vector. The region sequenced is marked with a black bar, and represents a 459-nt-long region spanning nt 666–1125 in
the NL4-3 sequence.
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transfection with the VSV-g expression vector, although the
number of replication cycles is likely to be limited.
COS-1 cells were co-transfected with pHCMV-G (which
encodes VSV-g) and either pDHIV.3.B71 or pDHIV.3.-
Thy.1.JRCSF.KL9. The resulting VSV-g pseudotyped pa-
rental viruses were concentrated by centrifugation to
produce high-titer virus stocks and used to co-infect fresh
COS-1 cells at a multiplicity of infection (MOI) of 1.0 for
each parental virus. The infectious units/ml, measured from
five independent transfections, was 1.26  105 F 1.5 
105 for DHIV.3.B7.1 and 2.66  104 F 1.04  104 for
DHIV.3.Thy.1.JRCSF.KL9. After 24 h, the co-infected
cells were transfected with pHCMV-G to produce a
VSV-g pseudotyped virus stock that contained both homo-
zygous parental virions, in which both copies of genomic
RNA are either the NL4-3 or JR-CSF, as well as hetero-
zygous virions, which contain both parental RNA
genomes. The virus stocks generated from these co-infec-
tions were used to infect H9 cells at a MOI of 0.01.
Genomic DNA was isolated after 48 h and the 5.1-kb
region from the DIS hairpin through vpr was amplified
using PCR. These PCR products were cloned into E. coli
and a 459-bp region encompassing the DIS hairpin wassequenced to determine the frequency and distribution of
crossovers. Clones from two separate infections using two
independently generated virus stocks from dually infected
cells were analyzed.
Estimating the efficiency with which heterozygous
virions are produced is important because previous work
had demonstrated that recombinant viruses are rarely
detected after reverse transcription unless the two parental
strains are co-packaged (Hu and Temin, 1990a). We
analyzed the efficiency of infection at Step 2, using flow
cytometry. After co-infection, approximately 40% of the
cells were dually infected, and expressed both Thy1.2
and B7.1 cell surface proteins. Approximately 40% of
cells were uninfected, expressing neither marker, and
approximately 20% of the cells were singly infected,
expressing either B7.1 or Thy.1. Experiments using iso-
type control antibodies demonstrated that the staining
seen was specific for Thy1.2 and B7.1 (data not shown).
Dual staining of singly infected cells also confirmed the
specificity of antibody staining (data not shown). The
relative proportion of dually infected cells was also
approximately 40% in a second independent experiment.
These studies demonstrate that dual infection occurred
efficiently and reproducibly.
Fig. 2. Detection of HIV-1 recombination in cell culture, experimental design. Step 1. Generation of parental virus stocks. Schematic versions of the vectors
from Fig. 1 are shown at the top. COS-1 cells were co-transfected with either pDHIV.3.B7.1 or pDHIV.3.Thy-1.JRCSF.KL9 and pHCMV-G. Parental viruses
DHIV.3.B7.1 and DHIV.3.Thy-1.JRCSF.KL9 are shown as red or green hexagons, respectively. Step 2. Generation of virus from cells infected with both
parental stocks. COS-1 cells were co-infected with the two parental stocks and then transfected 24 h later with pHCMV-G. B7.1 and Thy.1 protein expressed on
the surface of the co-infected COS-1 cell are diagrammed in blue and purple, respectively. The virus stock harvested on day 5 contains a mixture of virions.
Parental virions are shown in red or green and the heterozygous virions are shown in yellow. Step 3. Infection of H9 with virus produced from dually infected
cells. Recombinant virus stocks were used to infect H9 cells at a low MOI (0.01). Total DNA was isolated from infected cells, PCR-amplified, cloned into
Escherichia coli, and serial clones were sequenced across a 459-bp region encompassing the DIS and the first part of gag.
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Recombinants were identified by sequence analysis of
PCR-amplified proviral DNA from cells infected by virus
produced by dually infected cells. We screened 163 clones
from the infection using the initial virus stock described
above, and 75 clones from a second independently generated
virus stock. There are 31 individual base pair differences
between NL4-3 and JRCSF in the 459-bp region chosen for
sequencing. We defined nucleotide changes that were less
than three bases apart as a single marker, resulting in 25
markers for the purpose of identifying recombinants (Fig. 3).Each clone was aligned against NL4-3 and JRCSF, and the
position of each marker was categorized as being character-
istic of either the NL4-3 or JRCSF parent. For the six markers
that consisted of two nucleotides, only changes in both bases
of the marker were counted as a crossover events. Five clones
from the pooled experiments had only single nucleotide
changes at one of these six markers; these nucleotide changes
were therefore not counted as crossover events.
Using the first virus stock from dually infected cells, 33/
163 (20%) of screened clones had a recombination event
within the 459-bp region sequenced (Fig. 3A). Fifteen of
these recombinant clones (45%) had a single crossover
Fig. 3. Types of crossovers observed. The 459-bp region sequenced is represented as a horizontal line at the top, divided into four regions of equal length. The
location of the DIS is marked with a black bar. NL4-3 sequence is shown in solid red; the JRCSF sequence in hatched green. Position of each sequence marker
is shown as a dark oval. Panels A and B represent results from two independent experiments. Clones screened are grouped as to whether they exhibited one,
two, or three crossovers. No clones with greater than three crossovers in this region were observed. Positions of crossovers are marked by changes in the color
and pattern of the horizontal lines.
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clones (15%) had three crossovers each. Using the second
heterozygous stock, 12/75 (16%) of screened clones had a
recombination event over the 459-bp region sequenced (Fig.
3B). Four of these recombinant clones (33%) had a single
crossover event each, 6 clones (50%) had two crossovers
each, and 2 clones (17%) had three crossovers each. The
disproportionate occurrence of double and triple crossovers
observed in each experiment likely is an example of the
previously observed phenomenon of high negative interfer-
ence (Hu et al., 1997).
The frequency of recombination seen using this model
system was approximately 3-fold higher than frequency of
recombination during PCR. When proviral DNA from cells
infected separately with each parental stock were pooled
before PCR amplification, 6/101 (6%) of clones contained
one or more crossovers. Four clones had a single crossover
each while only two clones had double crossovers. No
clones with triple crossovers were seen.
Distribution of crossover events
The distribution of crossovers is shown in Fig. 4 for each
heterozygous stock. Because the distances between markers
are not uniform, the recombination frequency within each
marker segment was corrected for distance. For this correc-
tion, the proportion of crossovers between two markers was
divided by the number of nucleotides between the markers.
Because the likelihood of recombination may be propor-
tional to the length of the homologous region between the
two parental strains, the distance-corrected recombination
frequency should reflect the likelihood of recombination at
each marker, independent of distance.Fig. 4. Distribution of crossovers. The x-axis lists the markers for recombination ev
divided by the total number of crossovers that occurred over the entire region, d
marker represent the distance-corrected crossover frequency between that marker
stock (solid black bars) and second heterozygous stock (striped bars) are shownThe most striking result evident from the data presented
in Fig. 4 is that recombination frequency varied greatly
with location in this 459-bp-long region. Specifically,
recombination frequencies are very high in the region
between markers 5–9 in both experiments. In comparison,
recombination frequencies were lower between markers
1–4, 10–13, and 18–24. This difference was evident,
irrespective of whether the percent of crossovers at each
marker was corrected for distance. The significance of
moderate to high crossover frequencies at certain markers
(e.g., 14, 17, and 25) is unclear, because these events were
observed in only one of the two experiments. The region
spanning markers 5–9 accounted for 64% (35/54) of all
crossovers in experiment #1 and 61% (14/23) of the
crossovers in experiment #2. This 112-nt-long region
was only one-quarter the length of the region sequenced.
This preferred region for recombination begins 30 bases
upstream of the gag AUG and extends 82 nt into the
coding sequence. In contrast, the 112-nt-long regions
upstream and downstream of this preferred region
accounted for only 10% and 14% of the recombination
events, respectively.
PCR-mediated recombination did not appear to be the
basis for the preferred region of recombination that we
observed. There were eight crossover events within the six
clones that recombined in the PCR control experiment. One
crossover occurred in the region encompassing markers 1–
4, three occurred in the region encompassing markers 5–10,
two occurred in the region including markers 11–16, and
three occurred in the region from markers 17–25. Thus, the
overall rate of PCR-mediated recombination was relatively
low with a fairly even distribution of crossovers over the
region sequenced.ents, numbered 1–25. The y-axis is the number of crossovers at each marker
ivided by the number of bases between each marker. Bars shown for each
and the marker immediately upstream. Results from the first heterozygous
separately.
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To better understand and analyze characteristics of the
gag-associated transfers, we designed a simple in vitro
transfer system. The intention here was to determine wheth-
er the transfer profile observed in the virus could be
reproduced in vitro. This approach would then allow us to
identify factors that contribute to the creation of the pre-
ferred transfer site. The system was designed such that
primer switching from the donor RNA onto the acceptor
RNA followed by completion of synthesis on the acceptor
C. Dykes et al. / Viro268Fig. 5. An in vitro system to analyze template switching catalyzed by HIV-1 RT du
the 5V-UTR-gag RNA templates. A schematic representation of the HIV-1 genom
panel. Regions and nucleotide positions in the genomic RNA that correspond to th
represent the NL4-3 donor (black) and JRCSF acceptor (gray) RNA templates. H
templates. Regions corresponding to the PBS and DIS sequences are indicated. Syn
to the 3V-end of the donor. (B) Strand transfer assays catalyzed by HIV-1 RT. Minu
labeled DNA primer (P) in the presence of the acceptor RNA. Reactions were term
resolved on a 6% polyacrylamide gel under denaturing conditions. Full-length synt
resulting from template switching and synthesis on the acceptor generated a 374-n
acceptor. Arrowheads on the right side of the gel indicate the major RT pause sites
positions in the cDNA. Pause sites corresponding to the SD hairpin (SD) and thewould yield transfer products that are longer and therefore
easily distinguished from the non-recombinant donor exten-
sion products (Fig. 5A). The donor and acceptor templates
shared a homology of 320 nts, extending from the PBS to
the beginning of gag. Primer extensions performed in the
presence of the acceptor template yielded a 374-nt transfer
product, in addition to the 354-nt full-length donor exten-
sion product (Fig. 5B). Transfer efficiency is calculated as,
100 transfer products/(transfer products + products of full-
length extension on donor). At 60 min, 11–13% transfer
efficiency was measured, indicating that 11–13% of the full-ring minus-strand synthesis through the 5V-UTR-gag RNA. (A) Schematic of
e highlighting some of the prominent regions is included at the top of the
e 354-nt donor and 368-nt acceptor RNA templates are indicated. Bold lines
atched lines at the template ends denote plasmid-derived sequences in the
thesis was primed from a 20-nt DNA primer, MB24 (black arrow) annealed
s-strand synthesis was initiated on the donor RNA template using the 5V-end
inated at 2.5, 5, 10, 15, 30, 45, and 60 min (lanes 1–7) and products were
hesis on the donor (F) resulted in a 354-nt extension product, while products
t transfer product (T). Lane 8 is a donor extension reaction in the absence of
, while stars along with the numbers on the left indicate approximate marker
kissing hairpin (DIS) are also indicated. Lane L—25-base DNA ladder.
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acceptor after transfer. We note here that the 374-nt product
would consist of transfer products generated from single and
odd numbers of crossovers, where synthesis was completed
on the acceptor. Recombinants resulting from double and
even numbers of crossovers would complete synthesis on the
donor template and would therefore be indistinguishable
from donor extension products.
Distribution of strand transfer events in vitro
The donor and acceptor RNA templates were generated
from the NL4-3 and JRCSF molecular clones of HIV-1,
respectively. As with the analysis in vivo, the naturally
occurring sequence variations were used as markers to map
the crossover sites within the recombinant transfer products.Fig. 6. Distribution of transfers in vitro. Template description is same as in Fig. 5
single, or double nucleotide base differences between the donor and acceptor te
determining the region of primer terminus transfer. (A) Transfer products were isol
of crossover sites within the template. Bars between two markers represent tran
transfers within marker segment/total transfers analyzed). Values from three indepe
presented. Only products resulting from single crossover events were included in th
recombinant products (solid bars) to those generated by RT-mediated template swi
were separately generated from donor and acceptor templates. Equal amounts of e
for details). Values were averaged from a minimum of three independent experim
recombinants was normalized to the observed average transfer frequency of 20%. T
estimated PCR transfer frequency at each site from the observed average transfer f
the segment length in nucleotides indicated in italics.To determine whether RT template switching within the 5V-
untranslated region (UTR) and early part of gag showed
features similar to those observed during reverse transcrip-
tion in the virus, the transfer products were isolated, cloned,
and sequenced. Fig. 6A presents the distribution of cross-
over sites as determined from three independent experi-
ments. Note that unlike the case with the cell culture
recombinants, only crossovers through marker 14 can be
analyzed. The bulk of transfer products resulted from a
single template-switching event per template. An average of
1 in 30 clones was the result of triple crossovers within a
template. Only products of single crossover events were
included in the analysis in Fig. 6A.
Crossovers were observed across the length of the
template, indicating that most regions within the in vitro
template had the potential to support some homologous. Open circles on the templates correspond to relative positions of natural,
mplates, and are designated as markers 1 through 14. These were used in
ated, amplified by PCR, cloned, and sequenced to determine the distribution
sfer frequency within that marker segment and were calculated as (100 
ndent experiments, each comprising of about 45–50 recombinant clones, are
e analysis. (B) Comparing crossover distribution profiles of PCR-generated
tching (hatched bars). For examining PCR-generated recombinants, cDNAs
ach were mixed together and amplified by PCR (see Materials and methods
ents, each consisting of 45–50 recombinant clones. The frequency of PCR
he estimated frequency of RT recombinants was obtained by subtracting this
requency shown in A. Marker segments are highlighted by parenthesis, with
C. Dykes et al. / Virology 326 (2004) 262–279270recombination (Fig. 6A). The distribution profile did not
reveal any striking preference or high frequency of
crossovers at the dimerization site. In fact only 20–
30% of the total crossovers occurred within the 84-nt
segment at the end of the template, following marker 2.
About 30–40% of transfers mapped to the 88-nt segment
between markers 2 and 5. This region spans from the
DIS hairpin to 18 nt into gag. Finally, 45–50% of
crossovers were localized within the 110-nt segment
between markers 5 and 11, comprising the 5V-end of
gag coding region.
To address the contribution of PCR-generated recombi-
nants, cDNA extension products independently generated
using the donor and the acceptor RNAs were mixed together
in equal quantities, and subjected to identical PCR amplifi-
cation conditions as the transfer products. The amplified
products were cloned and sequenced. Faithful amplification
should yield products having the pure donor or pure
acceptor sequences. Results from four independent experi-
ments revealed that 15–25% of the amplified products
contained markers from both donor and acceptor. This
meant that 15–25% of the recombinants analyzed were
very likely generated by PCR. We therefore analyzed the
crossover sites within the PCR recombinants. Fig. 6B
compares the distribution of sites for the PCR-generated
crossovers (corrected for the observed f20% transfer
frequency) and the crossovers estimated to be due to RT
alone (obtained by subtracting the PCR-generated crossover
frequency from the observed crossover frequency at each
marker). Interestingly, crossover sites of the PCR recombi-
nants showed a distinctly different distribution profile than
the RT-generated recombinants, with the bulk of the cross-
overs occurring in the template segment between markers 1
and 5. This suggested that the preferred region of crossoversFig. 7. Comparison of the crossover distribution profiles of the cell culture and in v
recombination events that were in common between the in vivo and in vitro exp
marker divided by the total number of crossovers that occurred over the entire regi
each marker represent the percentage of crossovers that occurred between th
heterozygous stock (solid black bars) and second heterozygous stock (light gray ba
within each marker segment as shown in Fig. 6A, was divided by the length of that
in vivo experiments.in gag was genuine and not influenced by the PCR-gener-
ated recombinants.
Comparison of recombinants from cell culture and in vitro
To compare the crossover profiles of the cell culture and
in vitro generated recombinants, the distance-corrected
distributions were plotted together (Fig. 7). Regions up-
stream of marker 1 and downstream of marker 14 were
excluded, as these regions were not common to both
systems. Distance correction for results in vitro was done
in the same way as for the cell culture data, by dividing the
frequency of crossovers measured between two given
markers by the distance between those markers. Signifi-
cantly, the two profiles showed similarities in that a higher
frequency of crossovers occurred in the start of the gag
region (markers 5–9). In both systems, relatively fewer
crossovers occurred in the template region downstream of
marker 9. A slightly higher frequency of crossovers were
observed in the PBS-DIS region (markers 1–3) in the in
vitro system as compared to the cell culture-based system.
A proportion of these likely represent PCR recombinants,
as suggested from Fig. 6B.
Sequence features of the preferred site for recombination in
gag
The sequence content of the preferred site for recombi-
nation at the 5V-end of gag (markers 5–9) differed signif-
icantly from another region incorporating markers 17–25 in
which recombination was much less frequent. The gag
region had 35 crossovers in the first experiment, was 112
nt long, had a GC content of 51% (57/112) and a purine
content of 72%. There were 46 G residues throughout theitro generated recombinant cDNA products. The x-axis lists the markers for
eriments, numbered 1–14. The y-axis is the number of crossovers at each
on, corrected for the number of bases between each marker. Bars shown for
at marker and the marker immediately upstream. Results from the first
rs) are shown separately. For the in vitro recombinants, crossover frequency
marker segment, to allow comparison with the crossover frequency from the
C. Dykes et al. / Virology 326 (2004) 262–279 271entire sequence and there were 4 independent stretches of 3
or more G residues. In contrast, the region encompassed by
markers 17–25 had only two crossovers in the first exper-
iment, had a lower GC content of 37% (41/111), and a
similar purine content of 66% (73/111). There were half as
many G residues (25) in this region, and no stretches of 3 or
more G residues.
Distribution of recombination events and base substitutions
In the course of analyzing the sequences of clones
obtained in the cell culture system, we noted the presence
of a number of mutations (these are marked in blue in Fig.
8). The occurrence of these mutations appeared to cluster in
specific regions (see, e.g., the region between markers 2 and
3 in Fig. 8). We therefore characterized the frequency,
nature, and distribution of mutations in all sequenced
clones. This was done to determine the correlation between
crossover events and mutations, and to establish whether
certain segments of the analyzed sequence were more
mutagenic than others.
Only 3 of 369 mutational events were deletions; no
nucleotide insertions were observed. G to A substitutions
were the most frequent and comprised 63.1% and 50.6% of
all substitutions observed in the first and second experi-
ments, respectively. A to G substitutions were second in
order of frequency. The remaining types of base substitu-
tions occurred at a frequency of less than 5%. The overall
mutation frequency and type of base substitution were
similar between recombinant and non-recombinant clones
(data not shown).
Mutation frequency differed widely among the segments
defined by the recombination markers. For example, muta-
tion frequencies (corrected for length) for regions defined by
markers 3, 5, and 8, are much higher than rates in regions
defined by markers 4, 10, 12, 16, and 23 (data not shown).
These differences were seen in both recombinant and non-
recombinant clones. The preferred sites for mutations
appeared to contain primarily G to A substitutions, and
were observed almost exclusively in regions where there
were runs of three or more G residues (see Fig. 8, in the
regions between markers 2–3, 4–5, 5–6, 7–8, 14–15).
These preferred sites for mutation were observed in recom-
binant as well as non-recombinant clones (data not shown).
Mutations at these sites did not occur more commonly in
clones that recombined at the adjacent markers compared to
clones that did not recombine at the adjacent markers (data
not shown).
There was some overlap between areas that were more
likely to undergo recombination events, and those at which
mutations were more likely to occur. However, there were
exceptions to this finding. For example, region 3 underwent
frequent mutation but had low levels of recombination.
Thus, the two events were not strictly linked.
To assess the contribution of PCR to the types and
distribution of mutations observed in the cell culturesystem, we cloned and sequenced amplified products from
PCR reactions, using cloned pNL4-3 DNA as substrate and
similar reaction conditions as the proviral DNA amplifica-
tions. The three most frequent types of mutations that
occurred during PCR in the absence of reverse transcrip-
tion were A to G (40%), T to C (26%), and G to A (23%)
substitutions. G to A mutations were therefore less com-
mon during PCR than during HIV infection (23% vs. 51–
63%, respectively) and there were no observed hotspots for
G to A mutations in runs of G residues. While PCR may
contribute to the overall rate of mutation we observed, it
does not appear to be responsible for the high percentage
of G to A mutations, or the preference for G to A
substitutions in stretches of G residues seen after reverse
transcription.Discussion
It is important to determine whether recombination
occurs randomly throughout the HIV genome, or whether
there are preferred sites for recombination. If such sites
exist, they could influence the location of recombination
events, particularly under circumstances in which the effec-
tive replicating pool of HIV is limited (see Brown, 1997 for
a more detailed discussion of this concept). Proposed
mechanisms for recombination during retrovirus replication
suggest that structure in the RNA templates and properties
of the proteins involved in replication would result in
preferred regions for crossovers (Balakrishnan et al., 2003;
Coffin, 1979; DeStefano et al., 1992, 1994; Harrison et al.,
1998; Peliska and Benkovic, 1992; Roda et al., 2002; Wu et
al., 1995). Specifically, regions that promote pausing of the
RT or interactions between the two genomic RNAs have
shown a propensity for primer transfer during synthesis in
vitro (Balakrishnan et al., 2001, 2003; DeStefano et al.,
1992, 1994; Diaz and DeStefano, 1996; Harrison et al.,
1998; Kim et al., 1997; Mikkelsen et al., 1998, 2000;
Palaniappan et al., 1996; Roda et al., 2002; Wu et al.,
1995). Analyses to date of recombination of HIV-1 in cell
culture demonstrate crossovers throughout the genome with
a suggestion of the existence of preferred locations (Jetzt et
al., 2000; Zhuang et al., 2002). We have identified the
presence of a preferred site of recombination near the 5V-end
of the gag gene, using a tissue culture system that allows a
fine analysis of crossover locations in the 5V-UTR and gag
regions of the HIV-1 genome. A parallel analysis of cross-
overs within the same sequences in vitro revealed the
consistent finding that this region of gag is a preferred site
for transfer events, supporting the hypothesis that this region
of the genome promotes recombination by HIV RT. The
power of this dual approach is that the cell culture system
shows recombination events in a biological setting, and the
reconstituted system allows for the identification of impor-
tant elements leading to recombination specificity within the
RNA and protein molecules employed. This relationship
C. Dykes et al. / Virology 326 (2004) 262–279272provides the key to the ultimate mechanistic interpretation
of natural recombination events.
Recent studies by Zhuang et al. (2002) suggested the
presence of local hotspots for recombination throughout the
genome and also identified a preferred location in the 5VFig. 8. Sequences of recombinant clones from Expt. #1. Sequences of each of the 3
JRCSF. NL4-3 sequence is shown in red. JRCSF sequence is shown in green. The
crossovers that occurred at each marker is shown at the bottom. Base substitutionregion of gag. Our tissue culture system also has the
potential to identify recombination events over a larger
region spanning the dimerization site in the 5V-UTR,
through the vpr coding sequence. Our system has some
novel features that facilitate a high-resolution analysis of3 recombinant clones identified from Expt. #1 were aligned with NL4-3 and
marker positions numbered 1–25 are shown at the top and the number o
s are shown in blue.f
Fig. 8 (continued).
C. Dykes et al. / Virology 326 (2004) 262–279 273recombination events. All of the progeny proviruses are
sequenced and no selection markers are used to enrich for
recombinants. This enables us to identify all recombinants
generated with no possible loss through selection. Because
recombination has been shown to occur in vitro within shortstretches of homology (DeStefano et al., 1997; Kim et al.,
1997; Palaniappan et al., 1996; Wu et al., 1995), recombi-
nation events measured over large regions of the genome
using lower resolution strategies such as HTA may not
detect some preferred sites of recombination.
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vitro lead to proposals that RT pausing during synthesis
results in a concentration of RNase H-directed cleavages of
the template genomic RNA near the pause site (DeStefano
et al., 1992, 1994, 1997; Roda et al., 2002). This localized
cleavage of genomic RNA reveals a single-stranded region
of the newly made primer that can interact with the other
genomic RNA to initiate the recombination event. Results
from the transfer assays in vitro presented here indicated a
possible correlation between the location of RT pausing
and the preferred region of crossovers in gag. Three
prominent pause sites were observed between markers 5
and 9, and correlated with the region were the bulk of
transfers occurred. Interestingly, locations of these pause
sites also correlated with homopolymeric nucleotide runs
in the template RNA. Homopolymeric nucleotide runs
have been shown to promote pausing by RT during
DNA synthesis (Ji et al., 1994; Klarmann et al., 1993).
Pausing promotes recombination, presumably because the
template is degraded more efficiently by the RNase H
activity of the enzyme when polymerization is stalled. This
increased degradation can then provide a location for the
second template to invade the enzyme/primer–template
complex and promote transfer of the RT and DNA primer
terminus (Balakrishnan et al., 2003; DeStefano et al., 1992,
1994; Kim et al., 1997; Roda et al., 2002; Wu et al.,
1995).
On the basis of in vitro studies of RNA dimerization,
the DIS sequence in HIV-1 has been postulated to be
responsible for initiating dimerization between the viral
RNA genomes (Laughrea and Jette, 1994; Paillart et al.,
1994, 1996, 1997). Earlier analyses of recombination had
suggested that the MLV DIS promotes crossovers, possi-
bly based on proximity of the RNA templates (Mikkelsen
et al., 1998, 2000). However, recent analyses of HIV-1
have shown that regions of the viral RNA containing the
DIS are not uniquely more recombinogenic than others
(Zhuang et al., 2002), an observation that is supported by
our data obtained both in vivo and in vitro. Our previ-
ously published analysis of recombination events promot-
ed by the HIV-1 DIS in vitro, using shorter RNA
templates, revealed a proximity effect facilitated by
DIS-induced template – template dimerization (Bala-
krishnan et al., 2001, 2003). This effect of the DIS on
recombination could be translated to other templates by
simply inserting the 35-nt DIS hairpin within an ectopic
sequence. The crossovers observed near the DIS in both
the MLV cell culture system and in vitro are likely
promoted by such a mechanism. On the basis of our
current analysis with longer templates containing the gag
region, we conclude that such proximity effects, though
existent, are very likely local and not dominant in the
context of large regions or the entire virus. It is also
possible that there are numerous other sites of low-
affinity interaction between long RNA templates that
provide a general alignment of sequences between thetwo templates. In such a case, the proximity effect at the
DIS would not particularly stand out in the context of the
entire viral genome.
We believe the crossovers we have described primarily
reflect recombination events occurring during reverse tran-
scription, rather than an artifact of PCR, based on the
differences in both the frequency and relative distribution
of crossovers observed in cell culture compared to PCR.
Moreover, the transfer distribution data obtained in vitro
matched the results obtained in culture, supporting their
validity. Although the number of replication cycles occur-
ring in our cell culture system is limited, we cannot
completely rule out the possibility that more than one round
of replication is occurring at the time of infection with
heterozygous virus. Therefore, we cannot define with cer-
tainty an absolute rate of recombination under these exper-
imental conditions.
Another novel feature of the studies presented here is
that the frequency and location of mutations can be
compared to recombination events. We have observed
that G to A mutations occurred at a high frequency
within homopolymeric runs of G residues. We also
identified some clones with G to A hypermutation, in
which serial G to A mutations occur (Vartanian et al.,
1991). This type of base substitution preferably occurs at
GpG or GpA dinucleotides (Janini et al., 2001; Vartanian
et al., 1991, 1994), but can also occur in homopolymeric
stretches of G residues (Vartanian et al., 1994). It has
been suggested that DNA synthesis by RT from a
template with homopolymeric stretches of Gs can deplete
dCTP pools, increasing the chance of misincorporation at
the end of the homopolymeric region. More recently, the
cellular protein APOBEC3G, a cytidine deaminase that is
expressed in human T lymphocytes (including the H9 cell
line), has been implicated in the production of retroviral
G to A hypermutation (reviewed in KewalRamani and
Coffin, 2003). Although an intact vif gene (which was
present in our HIV vectors) counteracts the mutagenic
effects of APOBEC3G in cell culture, overexpression of
APOBEC3G in a cell line that normally does not express
this cellular protein can induce G to A hypermutation in
HIV with an intact vif gene (Zhang et al., 2003). Thus,
the relative extent to which HIV RT and APOBEC3G
contribute to the G to A mutations observed in our model
system is not clear at present.
In summary, we have defined a region of the HIV-1
genome near the beginning of gag that is much more
recombinogenic than surrounding regions of the 5V-UTR
and gag. The presence of this preferred site for recom-
bination may influence the likelihood of progeny viruses
having a recombination event at this site, under condi-
tions in which the effective replicating pool of HIV-1 is
limited. The preferred site is flanked by similar sized
areas that are virtually inert for recombination. Analysis
of recombination over the same sequences in vitro
recapitulated the preferred site for recombination. The
C. Dykes et al. / Virology 326 (2004) 262–279 275profile and location of pause sites within this region
implies a role for RT pausing in promoting the transfers.
These results present a basis for future work to analyze
the mechanistic basis of actual recombination events in
vivo. In addition, we have identified that this region in
gag also undergoes frequent G to A substitutions, which
cluster in regions of homopolymeric stretches of G
residues. Highly G-rich regions may promote both re-
combination and G to A substitutions, but these most
likely occur through independent mechanisms. The ex-
perimental cell culture model system described here
should prove useful in defining whether other regions
of the HIV-1 genome are also highly prone to undergo
recombination or mutation, and to correlate sequence
features with the likelihood of these events.Materials and methods
Reagents
The following reagents were obtained through the AIDS
Research and Reference Reagent program, Division of
AIDS, National Institute of Allergy and Infectious Diseases:
the infectious molecular clone pNL4-3 was obtained from
Malcolm Martin, pYK-JRCSF was obtained from Irvin SY
Chen and Yoshio Koyanagi, and the HeLa-CD4-LTR-h-gal
cell line was obtained fromMichael Emerman. pHCMV-G is
a vector which expresses vesicular stomatitis virus (VSV)-g
protein under the control of the human cytomegalovirus
immediate early promotor (Yee et al., 1994). pBJ-hB7.1
contains the leader sequence and extracellular domain of
the human co-stimulatory gene, B7.1 (Challita-Eid et al.,
1998). The vector HIV-1NL4-3-luc-env()vprX is a deri-
vative of pNL4-3 which has a deletion in env, the reporter
luciferase gene in place of nef, and a frameshift mutation at
codon 64 of the vpr open reading frame (Planelles et al.,
1995a). pHIV-thy-1 is a derivative of pNL4-3 in which nef
has been replaced with the mouse gene, Thy1.2 (Planelles
et al., 1995b). Recombinant HIV-1 RT (specific activity
20,000 units/mg) was supplied by the Genetics Institute
(Cambridge, MA). T7 RNA polymerase, T4 polynucleotide
kinase, DNase I, restriction endonucleases, dNTPs, rNTPs,
and RNase inhibitor were purchased from Roche (Indian-
apolis, IN) and E. coli RNase H from Invitrogen (Carlsbad,
CA).
Cell culture
COS-1, SV40-transformed African green monkey kidney
cells [American Type Culture Collection (ATCC), Manassas,
VA], were grown in the presence of Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS), L-glutamine (2 mM), penicillin (100
units/ml), and streptomycin (100 units/ml). HeLa-CD4-LTR-
h-gal cells were grown in DMEM supplemented with 10%FBS, L-glutamine (2 mM), penicillin (100 units/ml), strep-
tomycin (100 units/ml), hygromycin (100 Ag/ml; Sigma, St.
Louis, MO), and geneticin (200 Ag/ml; Sigma). H9 human
lymphoma cells (ATCC) were grown in RPMI supplemented
with 20% FBS, penicillin (100 units/ml), and streptomycin
(100 units/ml).
Construction of parental HIV vectors, pDHIV.3.B71, and
pDHIV.3.Thy1.JRCSF.KL9
The first parental vector, pDHIV.3.B71, derived from
pNL4-3, was designed to have a deletion of env and to
express the human co-stimulatory gene, B7.1, on the cell
surface of infected cells early after infection. B7.1 was
excised from the vector, pBJ-hB7.1 using HindIII and
XhoI. The HindIII end was filled in using the Klenow
fragment of E. coli DNA polymerase I. HIV-1NL4-3-luc-
env()vprX was digested with MluI and XhoI. The MluI
end was filled in using the Klenow fragment of E. coli
DNA polymerase I. The B7.1 fragment was then ligated to
the fragment from the HIV vector to produce pDHIV.4.B7,
which now had the B7.1 gene in place of nef. Because
pDHIV.4.B7 had an inactive vpr gene, a functional vpr
gene from pNL4-3 was substituted, by subcloning the 2.3-
kb AgeI–SalI fragment from pNL4-3 into pDHIV.4.B71,
to create pDHIV.3.B71 (Fig. 1). The integrity of the vpr
gene was confirmed by sequencing. Expression of B7.1
was confirmed by transfecting COS-1 cells with
pDHIV.3.B7.1 (Superfect; Qiagen, Santa Clarita, CA) and
staining with a B7.1 monoclonal antibody [a-B7.1-phyco-
erythrin (PE); Becton Dickinson, San Jose, CA], followed
by flow cytometry.
The second parental HIV vector, pDHIV.3.Thy1.
JRCSF.KL9, was designed to contain 5.1 kb from pYK-
JRCSF, spanning the DIS through vpr, have a deletion in env,
and to express the mouse gene product, Thy1.2, on the cell
surface of infected cells early after infection. A 0.7-kb
fragment of the envelope gene was deleted from the con-
struct HIV-Thy-1 using two BglII sites within the gp120-
coding sequence, to generate pDHIV.3.Thy-1. The 5.1kb
BssHII-SalI fragment from pYK-JRCSF, spanning the DIS
through vpr, was substituted for the corresponding NL4-3
sequence in pDHIV.3.Thy1 to create pDHIV.3.Thy1.JRCSF.
To identify recombinants across the DIS, a subclone of
pDHIV.3.Thy1.JRCSF was constructed and used to intro-
duce mutations corresponding to the JRCSF sequence up-
stream of the DIS hairpin (NL4-3 proviral positions 667–
668, T to A to A to G, respectively). The 2.9-kb AatII–SphI
fragment from pDHIV.3.Thy1.JRCSF was subcloned into
pQE-31 (Qiagen) to generate pQE-31-JRCSF. The two
nucleotide substitutions were introduced using PCR-mediat-
ed site-directed mutagenesis (Quikchange, Stratagene, La
Jolla, CA) and the following primers: QE-31/JRCSF-1 (5V-
GCGAAAGAGAAGCCAGAGG-3V) and QE-31/JRCSF-2
(5V-CCTCTGGCTTCTCTTTCGC-3V). The resulting clone,
pQE-31-JRCSF.KL9, was sequenced in both directions to
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spurious mutations (Perkin-Elmer/Applied Biosystems, Fos-
ter City, CA). The AatII –SphI fragment of pQE-31.
JRCSF.KL9 was subcloned into pDHIV.Thy1.JRCSF to
create pDHIV.Thy1.JRCSF.KL9 (Fig. 1). This vector was
sequenced from proviral bases 667–5801 to verify the
presence of the DIS mutation and confirm the published
sequence of JRCSF. The expression of Thy1.2 was verified
by transfection of COS-1 cells with pDHIV.Thy1.
JRCSF.KL9 (Superfect; Qiagen), followed by flow cytomet-
ric analysis using a FITC-conjugated anti-thy 1.2 antibody
(Caltag, Burlingame, CA).
Production of parental DHIV.3.Thy1.JRCSF and
DHIV.3.B71 viral stocks
COS-1 cells were transiently transfected with pHCMV-G
(Akkina et al., 1996; Burns et al., 1993), and either
pDHIV.3.Thy1.JRCSF.KL9 or pDHIV.3.B71 (Superfect;
Qiagen). Supernatants were harvested 72 h later and clari-
fied by centrifugation at 500  g. Virus stocks were
concentrated by ultracentrifugation and stored at 80 jC.
Relative infectious titers of each stock were determined
using HeLa-CD4-LTR-h-gal indicator cells, as previously
described (Kimpton and Emerman, 1992).
Production of virus from dually infected cells stocks
Twenty-four hours after seeding in 10-cm plates, 1  106
COS-1 cells were treated with 10 Ag/ml of polybrene
(Sigma) in PBS, and then co-infected with DHIV.3.
Thy1.JRCSF.KL9 and DHIV.3.B71 at a MOI of 1.0 for
each virus. Twenty-four hours after infection, cells were
transiently transfected with pHCMV-G (Superfect; Qiagen).
Supernatant was harvested 72 h later and clarified by
centrifugation at 500  g. The relative infectious titer was
determined using HeLa-CD4-LTR-h-gal cells as previously
described (Kimpton and Emerman, 1992). To measure the
efficiency of infection by each parental stock, one plate of
COS-1 cells was infected with the two parental viruses, but
not transfected with pHCMV-G. These cells were then
stained with FITC-conjugated Thy1.2 and PE-conjugated
B7.1 antibodies, and dually infected cells were quantitated
using flow cytometry.
Flow cytometry
Flow cytometric analysis was performed in a Facscan
(Becton-Dickinson) using the manufacturer’s recommen-
ded protocols. PE-conjugated-anti B71 antibody (Becton
Dickinson), anti-Thy1-FITC (Caltag), and their respective
isotype control antibodies [mouse IgG1n-PE (PharMingen,
San Diego, CA) and rat IgG2a-FITC (Caltag)] were
diluted 1:10 with phosphate-buffered saline (PBS) con-
taining 2% FBS, 0.5 mM EDTA, and 0.02% sodium
azide before use.Production and sequencing of proviral clones
H9 cells were infected with virus stock from dually
infected cells, at an MOI of 0.01 in the presence of 10 Ag/
ml of polybrene. After 72 h, aliquots of infected cell
pellets were harvested and frozen at 80 jC. Genomic
DNA was extracted from 1  106 H9 cells using the
QiaAmp DNA Blood Kit (Qiagen), and PCR amplified
using the Expand Long Template PCR system (Roche
Molecular Biochemical, Indianapolis, IN), and the follow-
ing primers: LTR-3 (5V-GCTCAAAGTAGTGTGTGCCC-
3V) and SAL-2 (5V-ACAAGCAGTTTTAGGCT-
GACTTCC-3V). The resulting 5 kb product, which includ-
ed the DIS hairpin, gag, pol, vif, and vpr, was cloned into
pCR-XL-TOPO (TOPO XL PCR cloning kit; Invitrogen)
and cloned DNA was purified from bacterial cultures
(Wizard SV 96 Plasmid DNA purification system; Prom-
ega, Madison, WI). Clones were digested with BamHI
(MBI Fermentas, Amherst, NY) before purifying the DNA
for sequencing (Strataprep 96 PCR purification kit; Stra-
tagene). Recombinant clones were identified by sequencing
a 459-base pair region spanning the DIS through the first
112 codons of gag (NL4-3 proviral nt 666–1125).
Determination of PCR recombination rate
To determine the PCR recombination rate, H9 cells were
infected at an MOI = 0.01 with either DHIV.3.B7.1 or
DHIV.3.Thy1.JRCSF.KL9. Forty-eight hours later, cells
were harvested and washed once with PBS, and harvested
cell pellets were frozen at 80 jC. Genomic DNA from
each separate infection was then pooled in a 1:1 ratio, and
amplified as described above. PCR products were cloned
and sequenced as described above.
Determination of the types and distribution of PCR
mutations
To assess the contribution of the PCR Expand enzyme to
the types and distribution of mutations in our system, we
PCR-amplified 10 ng of pNL4-3 using the same PCR
conditions that were used to amplify proviral DNA from
cells infected with heterozygous virus. This PCR product
was purified and cloned into pCR-XL-TOPO, and clones
were prepared for sequencing as described above (‘‘Produc-
tion and Sequencing of Proviral Clones’’).
Generation of RNA templates for in vitro strand transfer
assays
Genomic sequences from the NL4-3 and JRCSF strains
of HIV-1 were amplified by PCR and cloned into pBlue-
script II KS(+) (Stratagene), to create the pNL182-520
donor and pJRC150-502 acceptor constructs for generation
of RNA templates using an approach described previously
(Balakrishnan et al., 2001). PCR primers Sac1/PBS-187 (5V-
326 (2004) 262–279
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520 (5V-GTGGGATCCCCCAGTATTTGTCTACAGCC)
were used to amplify the genomic RNA region from the
PBS through gag position 520 to create the donor construct,
while primers Sac1/U5-150 (5V-CTCGAGCTCCCTTTTGT-
CAGTGTGGAAAATCTC) and JRC/BamH1-502 (5V-
GTCGGATCCCCTTCTGATGATTCTAACAGG) were
used to amplify the genomic region from the U5 position
150 through gag position 502 to create the acceptor con-
struct. Restriction enzyme sites within the primers are
underlined. PCR fragments were digested with Sac1 and
BamH1 and cloned into pBluescript II KS(+) (Stratagene).
RNA templates were prepared by in vitro run-off transcrip-
tion from BamH1 linearized plasmids as previously de-
scribed (Balakrishnan et al., 2001). Full-length transcripts
were purified on 6% denaturing polyacrylamide gel and
analyzed for integrity.
In vitro transfer assays
Assays were set up as previously described (Balak-
rishnan et al., 2001). Synthesis was initiated on the donor
template using the DNA primer MB24 (5V-CCCAG-
TATTTGTCTACAGCC). Briefly, the 5V-end labeled primer
(50 fmol) was mixed with donor (25 fmol) RNA in 50 mM
Tris–HCl, pH 8.0, 1 mM EDTA, and 50 mM KCl. Mixtures
were incubated at 80 jC for 1 min and slow-cooled to room
temperature to facilitate primer annealing. Transfer assays
were performed in 12 Al final reaction volume. Two units
(50 ng) of HIV-1 RT were preincubated for 2 min at room
temperature with 2 nM template termini of primer-template
and 8 nM acceptor, in 50 mM Tris–HCl, pH 8.0, 80 mM
KCl, and 1 mM DTT. Acceptor RNAwas excluded in donor
extension assays. Reactions were initiated by the addition of
MgCl2 and dNTPs at a final concentration of 6 mM and 50
AM, respectively. Following incubation at 37 jC, reactions
were terminated at the indicated times by addition of 12 Al of
termination buffer (90% formamide, 10 mM EDTA, pH 8.0
and 0.1% each of xylene cyanole and bromophenol blue).
Reaction products were resolved on 6% polyacrylamide–
urea gels and visualized by phosphorimaging using Image-
Quant software (Molecular Dynamics).
Analysis of transfer products
Transfer assays were performed for 1 h, the cDNA transfer
products were then PAGE purified, amplified by PCR using
primers Sac1/150 and BamH1/520, and cloned into pBlue-
script II KS(+) as previously described (Balakrishnan et al.,
2001). Individual clones, representing recombinant transfer
products, were sequenced using M13 (20) primers by
automated sequencing to identify crossover sites. To address
the contribution of PCR to the generation of false recombi-
nant products, cDNAs separately generated from primer
extensions on donor and acceptor RNA templates weremixed
together and subject to identical PCR amplification as thetransfer cDNAs. The amplified products were cloned and
sequenced to determine the percentage of recombinants
generated and the distribution of crossover sites in these
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